The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled ``Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Availability'' that appeared in the Federal Register of December 20, 2017. The Agency is taking this action to allow interested persons additional time to submit comments.
Document
Drug Products Labeled as Homeopathic; Draft Guidance for Staff and Industry; Availability; Extension of Comment Period
The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled ``Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 12398
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Drug Products Labeled as Homeopathic; Draft Guidance for Staff and Industry; Availability; Extension of Comment Period,” thefederalregister.org (March 21, 2018), https://thefederalregister.org/documents/2018-05659/drug-products-labeled-as-homeopathic-draft-guidance-for-staff-and-industry-availability-extension-of-comment-period.